Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Effects of rat C-peptide-II on lipolysis and glucose consumption in cultured rat adipose tissue.

Ghorbani A., Omrani GR., Hadjzadeh MA., Varedi M.

Animal Study on Systemic / IV, published in Exp Clin Endocrinol Diabetes (2011) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Exp Clin Endocrinol Diabetes (2011)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
21553365
DOI
10.1055/s-0031-1275662

Abstract (original English)

Existing data show that C-peptide (CP) prevents or ameliorates diabetes-related complications mainly by improving microcirculation and perhaps metabolism. Although effects of CP on muscle glucose consumption are relatively well studied, its effects on adipose tissue, a key organ involved in metabolism, are not well known. Therefore, the aim of this study was to examine the effects of CP on basal and stimulated lipolysis and glucose consumption in rat retroperitoneal (RP) adipose tissue, using an EX-VIVO organ culture setting. The RP adipose tissue was excised from adult male rats, minced and subjected to EX-VIVO culture for 24 h. The tissue fragments were then weighted and distributed into a 24-well culture plate. The wells were left untreated (basal) or treated with insulin or isoproternol (ISO, stimulated) and incubated in the absence or presence of CP, insulin or a combination of the both peptides. Levels of lipolysis and tissue glucose consumption were determined by glycerol and glucose concentrations measurement in the infranatant conditioned media collected from each well. The CP, like insulin, induced an insignificant reduction in basal lipolysis. While insulin significantly reduced the ISO-stimulated lipolysis, CP was ineffective. Tissue glucose consumption was significantly stimulated by insulin, but was not affected by CP. However, in the presence of CP, inhibitory ef

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsC-PeptideCell SurvivalCells, CulturedDrug Evaluation, PreclinicalEndothelial CellsGlucoseInsulinLipolysis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research